Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
miR-210 Enhances the Therapeutic Potential of Bone-Marrow-Derived Circulating Proangiogenic Cells in the Setting of Limb Ischemia.
Besnier M, Gasparino S, Vono R, Sangalli E, Facoetti A, Bollati V, Cantone L, Zaccagnini G, Maimone B, Fuschi P, Da Silva D, Schiavulli M, Aday S, Caputo M, Madeddu P, Emanueli C, Martelli F, Spinetti G. Besnier M, et al. Among authors: vono r. Mol Ther. 2018 Jul 5;26(7):1694-1705. doi: 10.1016/j.ymthe.2018.06.003. Epub 2018 Jun 15. Mol Ther. 2018. PMID: 29908843 Free PMC article.
Role of TPBG (Trophoblast Glycoprotein) Antigen in Human Pericyte Migratory and Angiogenic Activity.
Spencer HL, Jover E, Cathery W, Avolio E, Rodriguez-Arabaolaza I, Thomas AC, Alvino VV, Sala-Newby G, Dang Z, Fagnano M, Reni C, Rowlinson J, Vono R, Spinetti G, Beltrami AP, Gargioli C, Caporali A, Angelini G, Madeddu P. Spencer HL, et al. Among authors: vono r. Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):1113-1124. doi: 10.1161/ATVBAHA.119.312665. Arterioscler Thromb Vasc Biol. 2019. PMID: 31018661 Free article.
MicroRNA-15a and microRNA-16 impair human circulating proangiogenic cell functions and are increased in the proangiogenic cells and serum of patients with critical limb ischemia.
Spinetti G, Fortunato O, Caporali A, Shantikumar S, Marchetti M, Meloni M, Descamps B, Floris I, Sangalli E, Vono R, Faglia E, Specchia C, Pintus G, Madeddu P, Emanueli C. Spinetti G, et al. Among authors: vono r. Circ Res. 2013 Jan 18;112(2):335-46. doi: 10.1161/CIRCRESAHA.111.300418. Epub 2012 Dec 11. Circ Res. 2013. PMID: 23233752 Free PMC article. Clinical Trial.
Corrigendum to: "The genetics of exceptional longevity identifies new druggable targets for vascular protection and repair" [Pharmacol. Res. 114 (December) (2016) 169-174. doi: 10.1016/j.phrs.2016.10.028. Epub 2016 Nov 3].
Puca AA, Spinetti G, Vono R, Vecchione C, Madeddu P. Puca AA, et al. Among authors: vono r. Pharmacol Res. 2017 May;119:477. doi: 10.1016/j.phrs.2017.01.029. Epub 2017 Feb 11. Pharmacol Res. 2017. PMID: 28196703 No abstract available.
Increased antioxidant defense mechanism in human adventitia-derived progenitor cells is associated with therapeutic benefit in ischemia.
Iacobazzi D, Mangialardi G, Gubernator M, Hofner M, Wielscher M, Vierlinger K, Reni C, Oikawa A, Spinetti G, Vono R, Sangalli E, Montagnani M, Madeddu P. Iacobazzi D, et al. Among authors: vono r. Antioxid Redox Signal. 2014 Oct 10;21(11):1591-604. doi: 10.1089/ars.2013.5404. Epub 2014 Apr 1. Antioxid Redox Signal. 2014. PMID: 24512058 Free PMC article.
24 results